The Prostate

Cover image for Vol. 75 Issue 10

Early View (Online Version of Record published before inclusion in an issue)

Edited By: John T. Isaacs

Impact Factor: 3.566

ISI Journal Citation Reports © Ranking: 2013: 10/77 (Urology & Nephrology); 47/124 (Endocrinology & Metabolism)

Online ISSN: 1097-0045


  1. 1 - 21
  1. Original Articles

    1. Serum quantitative proteomic analysis reveals potential zinc-associated biomarkers for nonbacterial prostatitis

      Xiaoli Yang, Hongtao Li, Chengdong Zhang, Zhidi Lin, Xinhua Zhang, Youjie Zhang, Yanbao Yu, Kun Liu, Muyan Li, Yuening Zhang, Wenxin Lv, Yuanliang Xie, Zheng Lu, Chunlei Wu, Ruobing Teng, Shaoming Lu, Min He and Zengnan Mo

      Article first published online: 22 MAY 2015 | DOI: 10.1002/pros.23028

    2. Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patients

      Qinlong Li, Quanlin Li, Jill Nuccio, Chunyan Liu, Peng Duan, Ruoxiang Wang, Lawrence W. Jones, Leland W. K. Chung and Haiyen E. Zhau

      Article first published online: 19 MAY 2015 | DOI: 10.1002/pros.23011

    3. Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort

      Rohina Rubicz, Shanshan Zhao, Craig April, Jonathan L. Wright, Suzanne Kolb, Ilsa Coleman, Daniel W. Lin, Peter S. Nelson, Elaine A. Ostrander, Ziding Feng, Jian-Bing Fan and Janet L. Stanford

      Article first published online: 18 MAY 2015 | DOI: 10.1002/pros.23016

    4. Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone

      Vincenza Conteduca, Orazio Caffo, Lisa Derosa, Antonello Veccia, Elisabetta Petracci, Vincenzo Emanuele Chiuri, Matteo Santoni, Daniele Santini, Lucia Fratino, Francesca Maines, Sara Testoni and Ugo De Giorgi

      Article first published online: 15 MAY 2015 | DOI: 10.1002/pros.23014

    5. Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition

      Chengfei Liu, Wei Lou, Cameron Armstrong, Yezi Zhu, Christopher P Evans and Allen C. Gao

      Article first published online: 13 MAY 2015 | DOI: 10.1002/pros.23015

  2. Original Article

    1. Anti-angiogenic activity of PSA-derived peptides

      Kailash C. Chadha, Bindukumar Nair, Alejandro Godoy, Rajendram Rajnarayanan, Erik Nabi, Rita Zhou, Neel R. Patel, Ravikumar Aalinkeel, Stanley A. Schwartz and Gary J. Smith

      Article first published online: 11 MAY 2015 | DOI: 10.1002/pros.23010

  3. Original Articles

    1. Not all gleason pattern 4 prostate cancers are created equal: A study of latent prostatic carcinomas in a cystoprostatectomy and autopsy series

      Farshid Siadat, Jenna Sykes, Alexandre R. Zlotta, Najla Aldaoud, Shin Egawa, Dmitry Pushkar, Cynthia Kuk, Robert G. Bristow, Rodolfo Montironi and Theodorus van der Kwast

      Article first published online: 11 MAY 2015 | DOI: 10.1002/pros.23009

    2. Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men

      Thomas Nordstrøm Kjær, Marie Juul Ornstrup, Morten Møller Poulsen, Jens Otto Lunde Jørgensen, David Michael Hougaard, Arieh Sierra Cohen, Shadman Neghabat, Bjørn Richelsen and Steen Bønløkke Pedersen

      Article first published online: 4 MAY 2015 | DOI: 10.1002/pros.23006

    3. You have full text access to this OnlineOpen article
      A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer

      Dean A. Troyer, Tamara Jamaspishvili, Wei Wei, Ziding Feng, Jennifer Good, Sarah Hawley, Ladan Fazli, Jesse K. McKenney, Jeff Simko, Antonio Hurtado-Coll, Peter R. Carroll, Martin Gleave, Raymond Lance, Daniel W. Lin, Peter S. Nelson, Ian M. Thompson, Lawrence D. True, James D. Brooks and Jeremy A. Squire

      Article first published online: 4 MAY 2015 | DOI: 10.1002/pros.23003

    4. Association of ERG and TMPRSS2-ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels

      Alba Font-Tello, Núria Juanpere, Silvia de Muga, Marta Lorenzo, José A. Lorente, Lluis Fumado, Laia Serrano, Sergio Serrano, Josep Lloreta and Silvia Hernández

      Article first published online: 4 MAY 2015 | DOI: 10.1002/pros.23004

  4. Review Article

    1. Body Mass Index and mortality in men with prostate cancer

      Anna Cantarutti, Stephanie E. Bonn, Hans-Olov Adami, Henrik Grönberg, Rino Bellocco and Katarina Bälter

      Article first published online: 30 APR 2015 | DOI: 10.1002/pros.23001

  5. Original Articles

    1. Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer

      Sarah B. Peskoe, Corinne E. Joshu, Sabine Rohrmann, Katherine A. McGlynn, Sarah J. Nyante, Gary Bradwin, Adrian S. Dobs, Norma Kanarek, William G. Nelson and Elizabeth A. Platz

      Article first published online: 28 APR 2015 | DOI: 10.1002/pros.22998

    2. The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer

      Zhibin Chen, Ni Chen, Pengfei Shen, Jing Gong, Xiang Li, Tao Zhao, Banghua Liao, Liangren Liu, Zhenhua Liu, Xingming Zhang, Jiyan Liu, Zhufeng Peng, Xueqin Chen, Miao Xu, Haojun Gui, Peng Zhang, Qiang Wei, Qiao Zhou and Hao Zeng

      Article first published online: 27 APR 2015 | DOI: 10.1002/pros.23005

    3. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor

      Yan Wang, Gaolei Liu, Dali Tong, Henna Parmar, Donald Hasenmayer, Wenqiang Yuan, Dianzheng Zhang and Jun Jiang

      Article first published online: 20 APR 2015 | DOI: 10.1002/pros.23000

    4. Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial

      Christopher M. Heaphy, Gaurav Gaonkar, Sarah B. Peskoe, Corinne E. Joshu, Angelo M. De Marzo, M. Scott Lucia, Phyllis J. Goodman, Scott M. Lippman, Ian M. Thompson Jr, Elizabeth A. Platz and Alan K. Meeker

      Article first published online: 20 APR 2015 | DOI: 10.1002/pros.22997

    5. A randomized double-blind placebo controlled phase I–II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or “chemopromotion”?

      Paolo Gontero, Giancarlo Marra, Francesco Soria, Marco Oderda, Andrea Zitella, Francesca Baratta, Giovanna Chiorino, Ilaria Gregnanin, Lorenzo Daniele, Luigi Cattel, Bruno Frea and Paola Brusa

      Article first published online: 20 APR 2015 | DOI: 10.1002/pros.22999

    6. Expression of spermidine/spermine N1-acetyl transferase (SSAT) in human prostate tissues is related to prostate cancer progression and metastasis

      Wei Huang, Jens C. Eickhoff, Farideh Mehraein-Ghomi, Dawn R. Church, George Wilding and Hirak S. Basu

      Article first published online: 20 APR 2015 | DOI: 10.1002/pros.22996

  6. Review Articles

    1. The 21st Annual Prostate Cancer Foundation Scientific Retreat report

      Andrea K. Miyahira, Jonathan W. Simons and Howard R. Soule

      Article first published online: 20 APR 2015 | DOI: 10.1002/pros.22993

  7. Original Articles


  1. 1 - 21